Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | OBI-888 |
Synonyms | |
Therapy Description |
OBI-888 is a monoclonal antibody that binds to Globo H hexasaccharide 1 (Globo H) antigen, which has potential anti-tumor activity against Globo H-expressing tumor cells (Cancer Res 2019;79(13 Suppl):Abstract nr 4814). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
OBI-888 | OBI888|OBI 888 | OBI-888 is a monoclonal antibody that binds to Globo H hexasaccharide 1 (Globo H) antigen, which has potential anti-tumor activity against Globo H-expressing tumor cells (Cancer Res 2019;79(13 Suppl):Abstract nr 4814). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03573544 | Phase Ib/II | OBI-888 | This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. | Terminated | USA | 1 |